These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Interrelationship of abnormal family history in the first degree relatives and clinical phenotype of patients with polycystic ovary syndrome]. Wang Y; Mao WW; Chen YJ; Li MZ; Qiao J; Wang LN Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):756-60. PubMed ID: 18307903 [TBL] [Abstract][Full Text] [Related]
10. Genetic determinants of insulin action in polycystic ovary syndrome. Haap M; Machicao F; Stefan N; Thamer C; Tschritter O; Schnuck F; Wallwiener D; Stumvoll M; Häring HU; Fritsche A Exp Clin Endocrinol Diabetes; 2005 May; 113(5):275-81. PubMed ID: 15926113 [TBL] [Abstract][Full Text] [Related]
11. Phenotypic characteristics according to insulin sensitivity in non-obese Korean women with polycystic ovary syndrome. Park HR; Choi Y; Lee HJ; Oh JY; Hong YS; Sung YA Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S233-7. PubMed ID: 17606307 [TBL] [Abstract][Full Text] [Related]
12. Obesity and the polycystic ovary syndrome. Martínez-Bermejo E; Luque-Ramírez M; Escobar-Morreale HF Minerva Endocrinol; 2007 Sep; 32(3):129-40. PubMed ID: 17912153 [TBL] [Abstract][Full Text] [Related]
13. Detection of insulin resistance and its treatment in adolescents with polycystic ovary syndrome. Legro RS J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1367-78. PubMed ID: 12510993 [TBL] [Abstract][Full Text] [Related]
14. Polycystic ovary syndrome in adolescents. Kent SC; Legro RS Adolesc Med; 2002 Feb; 13(1):73-88, vi. PubMed ID: 11841956 [TBL] [Abstract][Full Text] [Related]
15. Development of polycystic ovary syndrome: involvement of genetic and environmental factors. Franks S; McCarthy MI; Hardy K Int J Androl; 2006 Feb; 29(1):278-85; discussion 286-90. PubMed ID: 16390494 [TBL] [Abstract][Full Text] [Related]
16. Polycystic ovary syndrome and type 2 diabetes mellitus. De Leo V; Musacchio MC; Morgante G; La Marca A; Petraglia F Minerva Ginecol; 2004 Feb; 56(1):53-62. PubMed ID: 14973410 [TBL] [Abstract][Full Text] [Related]
17. Treatment options of polycystic ovary syndrome in adolescence. Zapanti E; Kiapekou E; Loutradis D Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():208-13. PubMed ID: 16641862 [TBL] [Abstract][Full Text] [Related]
18. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes? Corbould A Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869 [TBL] [Abstract][Full Text] [Related]
19. Family history as a risk factor for the polycystic ovary syndrome. Azziz R; Kashar-Miller MD J Pediatr Endocrinol Metab; 2000; 13 Suppl 5():1303-6. PubMed ID: 11117675 [TBL] [Abstract][Full Text] [Related]
20. The role of genes in the polycystic ovary syndrome: predisposition and mechanisms. Deligeoroglou E; Kouskouti C; Christopoulos P Gynecol Endocrinol; 2009 Sep; 25(9):603-9. PubMed ID: 19591017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]